A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Liu, Chih-Pin, Ph.D. Research Bookmark and Share

Chih-Pin Liu, Ph.D. Research

T-cells and Immunity
T-cells play a central role in the generation of the host’s immunity to infections and tumors, and in the regulation of autoimmunity and allergy.  A critical prerequisite for selection and maturation of T-cells is cell surface expression of the T-cell antigen receptor (TCR) complex, which is responsible for recognition of antigens and for transmitting signals inside the cell. These processes are regulated by the interaction of TCR with antigens presented by major histocompatibility complex (MHC) molecules expressed on antigen presenting cells. Research carried out in this laboratory investigates the molecular and cellular mechanisms underlying T-cell mediated immunity against tumors and the roles of T-cells in regulating inflammatory and autoimmune diseases.

Mechanisms underlying T-cell-mediated Immunity
Recognition of the MHC/antigen complex by TCRs generates a series of signaling events that regulate the behavior and function of T-cells. To study the molecular and cellular mechanisms regulating T-cell mediated immunity, we will use state-of-art molecular and proteomics (the study of proteins) approaches to identify the molecules regulating the activation and apoptosis of normal T cells and T cell leukemia. We will also investigate the in vivo role of these molecules using transgenic and gene knockout mice. These proteins may serve as molecular targets for modulating the function of T-cells and for the further immunotherapeutic treatment of various types of cancers. Moreover, we will perform experiments to determine the mechanisms that regulate T-cell functions responsible for tumor immunity and autoimmunity.

Regulation of Autoimmune Disease
In autoimmune diseases, such as type 1 diabetes, presentation of autoantigens by disease-associated MHC plays a critical role in the selection and activation of disease-associated T-cells.  It is now known that T-cells not only function as pathogenic T-cells that cause the disease but also function as regulatory T-cells that inhibit the disease. It has been shown that antigen-specific regulatory T-cells are more potent than a heterogeneous population of regulatory T cells in suppressing pathogenic processes. Therefore, it is desirable to use antigen-specific regulatory T cells to modulate the function of pathogenic T-cells to prevent autoimmune disease. It has been historically very difficult for immunologists to identify and isolate a sufficient number of antigen-specific T cells for further studies. We have addressed this question using novel multivalent MHC/ antigen tetramers, and have identified and isolated several lines of antigen-specific regulatory T-cells. We have demonstrated that the isolated regulatory T-cells can effectively inhibit type 1 diabetes.  Based on these findings, we will investigate the molecular and cellular mechanisms underlying the regulation of pathogenic T cell by these regulatory T cells that lead to prevention of the disease.  We will also examine whether these potent regulatory T cells can be used as a treatment to prevent the immune destruction of islet grafts in an animal model for islet transplantation.
 

Chih-Pin Liu, Ph.D. Lab Members

Chih-Pin Liu, Ph.D.
Professor
626-256-HOPE (4673),ext. 63455

Weiting Du, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 63427

Jiangying Shen, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 6037

Ding Wang, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 65254

Wenhui Lee, M.S.
Senior Research Associate
Research Associate
626-256-HOPE (4673),ext. 65525

Yueh-Wei Shen
Research Associate II
626-256-HOPE (4673),ext. 65520

Liu, Chih-Pin, Ph.D. Research

Chih-Pin Liu, Ph.D. Research

T-cells and Immunity
T-cells play a central role in the generation of the host’s immunity to infections and tumors, and in the regulation of autoimmunity and allergy.  A critical prerequisite for selection and maturation of T-cells is cell surface expression of the T-cell antigen receptor (TCR) complex, which is responsible for recognition of antigens and for transmitting signals inside the cell. These processes are regulated by the interaction of TCR with antigens presented by major histocompatibility complex (MHC) molecules expressed on antigen presenting cells. Research carried out in this laboratory investigates the molecular and cellular mechanisms underlying T-cell mediated immunity against tumors and the roles of T-cells in regulating inflammatory and autoimmune diseases.

Mechanisms underlying T-cell-mediated Immunity
Recognition of the MHC/antigen complex by TCRs generates a series of signaling events that regulate the behavior and function of T-cells. To study the molecular and cellular mechanisms regulating T-cell mediated immunity, we will use state-of-art molecular and proteomics (the study of proteins) approaches to identify the molecules regulating the activation and apoptosis of normal T cells and T cell leukemia. We will also investigate the in vivo role of these molecules using transgenic and gene knockout mice. These proteins may serve as molecular targets for modulating the function of T-cells and for the further immunotherapeutic treatment of various types of cancers. Moreover, we will perform experiments to determine the mechanisms that regulate T-cell functions responsible for tumor immunity and autoimmunity.

Regulation of Autoimmune Disease
In autoimmune diseases, such as type 1 diabetes, presentation of autoantigens by disease-associated MHC plays a critical role in the selection and activation of disease-associated T-cells.  It is now known that T-cells not only function as pathogenic T-cells that cause the disease but also function as regulatory T-cells that inhibit the disease. It has been shown that antigen-specific regulatory T-cells are more potent than a heterogeneous population of regulatory T cells in suppressing pathogenic processes. Therefore, it is desirable to use antigen-specific regulatory T cells to modulate the function of pathogenic T-cells to prevent autoimmune disease. It has been historically very difficult for immunologists to identify and isolate a sufficient number of antigen-specific T cells for further studies. We have addressed this question using novel multivalent MHC/ antigen tetramers, and have identified and isolated several lines of antigen-specific regulatory T-cells. We have demonstrated that the isolated regulatory T-cells can effectively inhibit type 1 diabetes.  Based on these findings, we will investigate the molecular and cellular mechanisms underlying the regulation of pathogenic T cell by these regulatory T cells that lead to prevention of the disease.  We will also examine whether these potent regulatory T cells can be used as a treatment to prevent the immune destruction of islet grafts in an animal model for islet transplantation.
 

Lab Members

Chih-Pin Liu, Ph.D. Lab Members

Chih-Pin Liu, Ph.D.
Professor
626-256-HOPE (4673),ext. 63455

Weiting Du, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 63427

Jiangying Shen, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 6037

Ding Wang, Ph.D.
Research Fellow
626-256-HOPE (4673),ext. 65254

Wenhui Lee, M.S.
Senior Research Associate
Research Associate
626-256-HOPE (4673),ext. 65525

Yueh-Wei Shen
Research Associate II
626-256-HOPE (4673),ext. 65520
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.

Learn more about
City of Hope's institutional distinctions, breakthrough innovations and collaborations.
 
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...
  • When Gilbert Fresquez, 72, lost an excessive amount of weight in late 2012, he didn’t think much of it. He assumed it was a side effect from a recent surgery to remove a carcinoid tumor in his small intestine. It wasn’t until a couple of years later during a routine doctor’s visit that the retired […]
  • Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Among both men and women, the rates of new cancers have decreased in recent years. Death rates, meanwhile, have declined among women and have held stable among men. Specialists at City of Hope are internationally r...
  • The transplant patient had been hospitalized for a couple of months. A professional violinist, he hadn’t touched his instrument for too long, ever since chemotherapy had caused his skin to peel and his fingers to go numb; they were too sensitive even to touch the metal strings, much less make them sing. He had ...